Anthony D'Adamio, SVP & General Counsel at Bioventus Inc. (BVS), sold 1,294 shares at $11.99 ($16K) on 2022-02-14, disclosed to the SEC on 2022-02-15.
Scheduled sale ($16k) by SVP & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| BVS | SELL | 2025-02-20 | $45K | — | Filing → |
| BVS | SELL | 2024-12-26 | $123K | — | Filing → |
| BVS | SELL | 2024-06-25 | $33K | — | Filing → |